Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3051–3100 of 18622
On January 7, 2025, the Company announced the appointment of Richard F. Westenberger as Interim Chief Executive Officer, effective January 5, 2025.
On January 3, 2025, the Board of Directors (the “Board”) of Safe & Green Holdings Corp (the “Company”) approved the appointment of Michael McLaren as the Company’s Chief Executive Officer
On January 1, 2025, Steven. P. Mullins, the Chief Financial Officer and member of the board of managers of Bloom HoldCo LLC (the “Company”), resigned from all positions with the Company.
Additionally, effective upon the SPAC Merger Effective Time, the following Holdco executive officers were appointed: Christopher Riley was appointed Interim Co-Chief Executive Officer, Randy Seidl was appointed Co-Chief Executive Officer and Oanh Truong was appointed Interim Chief Financial Officer and Corporate Secretary.
Additionally, effective upon the SPAC Merger Effective Time, the following Holdco executive officers were appointed: Christopher Riley was appointed Interim Co-Chief Executive Officer, Randy Seidl was appointed Co-Chief Executive Officer and Oanh Truong was appointed Interim Chief Financial Officer and Corporate Secretary.
Additionally, effective upon the SPAC Merger Effective Time, the following Holdco executive officers were appointed: Christopher Riley was appointed Interim Co-Chief Executive Officer, Randy Seidl was appointed Co-Chief Executive Officer and Oanh Truong was appointed Interim Chief Financial Officer and Corporate Secretary.
Universal Biosensors, Inc. (the “ Company ”) announced that its board of directors (the “ Board ”) appointed Peter Mullin as Chief Financial Officer and Finance Director.
the Company and Salesh Balak, the Company’s Chief Financial Officer, mutually agreed that Mr. Balak will resign from his position as Chief Financial Officer at the Company.
announcing the retirement of its Chief Financial Officer, John Berg, and the appointment of his successor, Mike John-Williams, effective January 8, 2025
announcing the retirement of its Chief Financial Officer, John Berg, and the appointment of his successor, Mike John-Williams, effective January 8, 2025
As previously announced, Richard Hallé assumed the position of Chief Financial Officer of the Company effective January 1, 2025.
On December 31, 2024, Todd Dissinger retired as Chief Financial Officer of Natural Grocers by Vitamin Cottage, Inc. (the “Company”).
accepted the resignation for personal reasons of John Kallassy, the Company’s Interim Chief Financial Officer, effective on January 10, 2025.
On January 6, 2025, Xuqiang (Adam) Yang resigned from his position as Chief Financial Officer.
On January 4, 2025, the Board of Directors of Catheter Precision, Inc. (the “Company”) appointed Philip Anderson as Chief Financial Officer of the Company, effective January 6, 2025.
Ms. Margrit Thomassen, the Company’s previous Interim Chief Financial Officer, ceased serving in that capacity on January 6, 2025 and will continue in the role of Company Controller.
On June 30, 2025, Mr. Amato’s employment with the Company will end
On January 2, 2025, Ministry Partners Investment Company, LLC (the “Company”) announced that Brian S. Barbre, Senior Vice-President and Chief Financial Officer, has tendered his resignation and accepted a new employment opportunity.
As of the Effective Date, Mr. Jonathan Hunt will no longer serve as the Company’s Chief Financial Officer but will remain in his role as the Company’s Chief Accounting Officer and principal accounting officer.
On January 2, 2025, the Board of Directors (the “Board”) of Perspective Therapeutics, Inc. (the “Company”) appointed Mr. Juan Graham as the Company’s Chief Financial Officer and principal financial officer, in each case effective as of January 6, 2025
On January 6, 2025, Helios Technologies (the “Company”) announced that the board of directors of the Company (the “Board”) has promoted Sean Bagan to President and Chief Executive Officer of the Company, effective January 6, 2025.
Effective January 1, 2025, Jamie E. Samath was promoted to serve as Executive Vice President, Chief Financial Officer and Head of Business Technology of Intuitive Surgical, Inc. (the “Company”).
the Board of Directors appointed Mr. Lazar as interim Chief Executive Officer of the Company, effective as of the signing of the Purchase Agreement.
Mr. Spiro Rombotis resigned as Chief Executive Officer of the Company
Jerry A. Cheatham, the Vice President of Global Finance for the Company’s Industrial Paper Packaging segment and a 36-year finance leader within the Company, was appointed to the role of interim Chief Financial Officer.
Robert R. Dillard separated from his position as the Chief Financial Officer of Sonoco Products Company
Kecia L. Steelman, currently the Company’s President and Chief Operating Officer, will succeed Mr. Kimbell as President and Chief Executive Officer, effective January 6, 2025.
On January 6, 2025, Ulta Beauty, Inc. (the “Company”) announced that David C. Kimbell, the Company’s Chief Executive Officer, will retire from his position and from the Company’s Board of Directors
appointed Robert Nadolny, Vice President – Controller of the Company, as the Company's Chief Financial Officer
Mr. Baird, the Company's Chief Financial Officer and principal financial officer and principal accounting officer, transitioned out of these positions on the Effective Date, and was appointed Chief Commercial Officer of the Company.
On December 23, 2024, the Board of Directors (the “Board”) of Septerna, Inc. (the “Company”) appointed Gil M. Labrucherie as the Chief Financial Officer, principal financial officer and principal accounting officer of the Company, in each case, effective as of January 6, 2025.
Bahram Valamehr, Ph.D., MBA has succeeded Mr. Wolchko in each of the Subsidiary Roles, effective as of January 1, 2025.
J. Scott Wolchko retired from his positions as President, Chief Executive Officer (“CEO”), Chief Financial Officer, Treasurer, principal executive officer, principal financial officer and principal accounting officer of the Company, effective as of December 31, 2024
James Bernau, the Company’s current President and Chief Executive Officer, intends to discontinue as Chief Executive Officer once a new Chief Executive Officer is appointed
On January 3, 2025, Steven L. Lindsey, the President and Chief Executive Officer of Spire Inc. (the “Company”) began a leave of absence for health-related reasons.
In addition, on January 6, 2025, the Board removed Mr. Olsen from his position as the Company’s Chief Executive Officer without cause and appointed Greg Lipschitz as the Company’s Interim Chief Executive Officer.
In addition, on January 6, 2025, the Board removed Mr. Olsen from his position as the Company’s Chief Executive Officer without cause and appointed Greg Lipschitz as the Company’s Interim Chief Executive Officer.
On November 22, 2024, Toney Jennings, Chief Executive Officer, resigned as the Chief Executive Officer.
On November 25, 2024, William Regan, Chief Financial Officer, resigned as the Chief Financial Officer.
On January 3, 2025, Everything Blockchain Inc (the “Company”) appointed Arthur Rozenberg as Chief Executive Officer, effective immediately.
Jeff Huddleston resigned from his position as Interim Chief Financial Officer of the Company, effective January 6, 2025.
The board of directors (the “ Board ”) of Lazydays Holdings, Inc., a Delaware corporation (the “ Company ”), appointed Jeff Needles, age 48, as Chief Financial Officer and Corporate Secretary of the Company, effective January 6, 2025.
Joseph F. McGuire Appointment as Chief Financial Officer
On January 6, 2025, Paul J. Wyckoff was appointed Cemtrex’s Chief Financial Officer
On January 6, 2025, Generation Bio Co. (the “Company”) and Matthew Norkunas, MD, MBA agreed that they will enter into a separation agreement (the “Norkunas Separation Agreement”) for Dr. Norkunas’s departure as the Company’s Chief Financial Officer, effective as of January 10, 2025 (the “Effective Date”).
On January 6, 2025, the Board of Directors (the “Board”) of the Company elected Kevin Conway to serve as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective as of the Effective Date.
the Company further announced, as part of its planned succession, the appointment of Mr. Ryan Lada to succeed Mr. Clifford as Senior Vice President, Chief Financial Officer and Treasurer of the Company
On January 6, 2025, The AZEK Company Inc. (the “Company”) announced that Mr. Peter Clifford is resigning from his positions as Senior Vice President, Chief Operations Officer and Chief Financial Officer of the Company, effective January 24, 2025
Effective January 1, 2025, Nixxy, Inc. (the “Company”) appointed Yu-san “Debra” Chen Volpone as the Chief Executive Officer of the Company and as a member of the Company’s board of directors (the “Board”).
the Board of Directors appointed Stephen A. Vintz, the Company’s Chief Financial Officer, and Mark Thurmond, the Company’s Chief Operating Officer, to serve as Co-Chief Executive Officers
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.